Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs

Clinical Infectious Diseases

Volumn 41, Issue 10, 2005, Pages 1537-1540

  Pancharoen, Chitsanu ^a,e   Mekmullica, Jutarat ^b   Thisyakorn, Usa ^a   Kasempimolporn, Songsri ^c   Wilde, Henry ^c   Herzog, Christian ^d  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d Berna Biotech Ltd   (Switzerland)

^e KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADOLESCENT; ANTIBODY TITER; APPETITE DISORDER; ARTICLE; DIARRHEA; DOSE RESPONSE; DRUG COST; FATIGUE; FEVER; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; INJECTION PAIN; IRRITABILITY; MALAISE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; VACCINATION;

ADOLESCENT; ALUMINUM; CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; INFANT; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; THAILAND;

EID: 27644479578     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/497266     Document Type: Article

References (12)

1. World Health Organization (WHO). Hepatitis A vaccines: WHO position paper. Wkly Epidemiol Rec 2000; 75:38-44.
2. Health and Social Services. Universal hepatitis A immunization program.-State of Alaska Epidemiology Bulletin, 1995. Available at: http: //www.epi.hss.state.ak.us/bulletins/docs/b1995_32.htm. Accessed 10 October 2005.
3. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005; 294:194-201.
4. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005; 294:202-10.
5. World Health Organization (WHO). Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. WHO/EMC/ZOO/96.6. Geneva, Switzerland: WHO, 1997:1-25.
6. Carlsson U, Brudin L, Eliasson I, Hansson BG. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative. Scand J Infect Dis 1996; 28:435-8.
7. Brindle RJ, Morris CA, Berger R, Kurtz JB. Inadequate response to intradermal hepatitis A vaccine. Vaccine 1994; 12:483-4.
8. Loutan L, Bovier P, Althaus B, Glück R. Inactivated virosome hepatitis A vaccine. Lancet 1994; 343:322-4.
9. Mayorga Perez O, Herzog C, Zellmeyer M, Loaisiga A, Frösner G, Egger M. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. J Infect Dis 2003; 188:671-7.
10. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48(RR-12):1-37.
11. Frösner G, Bastos G, Zellmeyer M, Glück R, Herzog C. Intradermal versus intramuscular administration of a virosome formulated hepatitis A vaccine [abstract WeP304]. Clin Microbiol Infect 2000; 6(Suppl 1):238.
12. Pancharoen C, Mekmullica J, Kasempimolporn S, Thisyakorn U, Wilde H. Seroprevalence of hepatitis A virus antibody among children and young adults in Bangkok. J Med Assoc Thai 2001; 84:1477-80.